US Broker Ratings

Apogee Therapeutics, Inc. (APGE) Stock Analysis: Biotechnology Innovator with 65.61% Potential Upside

Investors with an eye on the biotechnology sector should keep Apogee Therapeutics, Inc. (APGE) on their radar. This clinical-stage company, headquartered in Waltham, Massachusetts, is making..

Travere Therapeutics, Inc. (TVTX) Investor Outlook: Strong Buy Ratings and Promising 28.82% Potential Upside

Travere Therapeutics, Inc. (TVTX), a prominent player in the biotechnology sector, is capturing investor attention with its robust pipeline of therapies targeting rare kidney and metabolic..

Alvotech (ALVO) Stock Analysis: Unpacking Potential 103.73% Upside in Biosimilar Market

Alvotech (NASDAQ: ALVO), a Luxembourg-based innovator in the biosimilar drug manufacturing sector, presents itself as a compelling opportunity for investors, particularly those with an eye on..

Certara, Inc. (CERT) Stock Analysis: Navigating a 19.82% Potential Upside in the Healthcare Sector

Certara, Inc. (NASDAQ: CERT) stands as a formidable player in the healthcare sector, specifically within the health information services industry. With a market capitalization of $1.98..

PACS Group, Inc. (PACS): Analyst Ratings Reveal 173% Potential Upside for Healthcare Investors

For investors seeking opportunities in the healthcare sector, PACS Group, Inc. (PACS) offers a compelling narrative. Operating within the medical care facilities industry, PACS Group is..

Janux Therapeutics, Inc. (JANX) Stock Analysis: A Biotech with 192% Potential Upside in Cancer Immunotherapy

Janux Therapeutics, Inc. (NASDAQ: JANX) is capturing significant investor attention in the biotechnology sector, fueled by its innovative approach to cancer immunotherapy and a stunning potential..

Sotera Health Company (SHC) Stock Analysis: Navigating a Strong Market Cap and Promising Revenue Growth

Sotera Health Company (NASDAQ: SHC), a pivotal player in the healthcare sector’s diagnostics and research industry, has attracted significant attention from investors. Headquartered in Broadview Heights,..

Mirum Pharmaceuticals, Inc. (MIRM): Investor Outlook on a Biotech with 14.4% Upside Potential

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) has captured the attention of investors with its promising portfolio of innovative therapies targeting rare and orphan diseases. With a market..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Unveiling a Potential 102% Upside in the Biotech Sector

Dyne Therapeutics, Inc. (NASDAQ: DYN), a fascinating player in the biotechnology sector, offers investors a unique opportunity to explore a company focused on pioneering therapies for..

Galapagos NV (GLPG) Stock Analysis: Navigating a Challenging Biotech Landscape Amidst a 26.12% Potential Downside

Galapagos NV (GLPG), a biotechnology company with a focus on oncology and immunology, is navigating a complex and competitive landscape within the healthcare sector. Headquartered in..

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: Exploring a Compelling 10.27% Potential Upside

Kymera Therapeutics, Inc. (KYMR), a healthcare standout in the biotechnology industry, has been attracting significant investor interest recently. With a market capitalization of $4.33 billion, this..

Immunovant, Inc. (IMVT) Stock Analysis: Exploring a Potential 99% Upside

Immunovant, Inc. (NASDAQ: IMVT), a clinical-stage immunology company, is drawing significant interest from investors, primarily due to its promising pipeline of monoclonal antibodies aimed at treating..

Protagonist Therapeutics, Inc. (PTGX) Stock Report: Exploring a $4.82 Billion Biotech’s Growth Trajectory and Analyst Confidence

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) is making waves in the biotechnology sector with its innovative approach to peptide therapeutics. Headquartered in Newark, California, this biopharmaceutical company..

Bausch Health Companies Inc. (BHC) Stock Analysis: Evaluating the 12.26% Potential Upside

Bausch Health Companies Inc. (NYSE: BHC) stands as a significant player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. Headquartered in..

NovoCure Limited (NVCR) Stock Analysis: Exploring an 86% Potential Upside in the Innovative Oncology Space

For investors eyeing the healthcare sector, NovoCure Limited (NASDAQ: NVCR) presents an intriguing opportunity. As a prominent player in the medical devices industry, NovoCure focuses on..

Centessa Pharmaceuticals (CNTA) Stock Analysis: A Biotech Powerhouse with 42% Upside Potential

Centessa Pharmaceuticals plc (NASDAQ: CNTA), a clinical-stage biotechnology company based in the United Kingdom, is making waves in the healthcare sector with its innovative approach to..

LeMaitre Vascular, Inc. (LMAT): Investor Outlook on a 18.88% Potential Upside

LeMaitre Vascular, Inc. (NASDAQ: LMAT) continues to draw attention within the healthcare sector, particularly in the medical instruments and supplies industry, as investors take note of..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Unpacking a 52% Potential Upside Amid Cutting-Edge Biotech Innovations

Beam Therapeutics Inc. (NASDAQ: BEAM) is capturing investor attention with its promising pipeline of precision genetic medicines, reflected in a substantial potential upside of 52.24%. The..

Progyny, Inc. (PGNY) Stock Analysis: Exploring a 43.91% Potential Upside in the Healthcare Sector

Progyny, Inc. (NASDAQ: PGNY), a key player in the healthcare sector, has been capturing investor attention with a compelling story in the fertility and family building..

Enovis Corporation (ENOV) Stock Analysis: Exploring a 53% Potential Upside in Healthcare Innovation

Enovis Corporation (NYSE: ENOV), a key player in the healthcare sector, specializes in medical devices designed to provide differentiated clinical solutions. Headquartered in Wilmington, Delaware, Enovis..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds